Teva Pharma AG - Lenalidomid-Teva 7.5 mg, Hartkapseln | | 67460 | | 03 | | Lenalidomid-Teva 7.5 mg | | Hartkapseln | | L04AX04 | | Lenalidomide | | 05.11.2019 | | |
| Composition | lenalidomidum 7.5 mg ut lenalidomidi hydrochloridum monohydricum, silica colloidalis anhydrica, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.018 mg, talcum, Kapselhülle: gelatina, E 171, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, E 172 (nigrum), kalii hydroxidum, pro capsula. | Packungsbestandteile | | Capsules | | | Principe actif | Concentr. |
---|
Lenalidomidum | 7.5 mg |
| BAG: Principe actif | Concentr. |
---|
Lenalidomidum | 7.5 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | (Nigrum) | | | Ammoniae Solutio | 30 | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | E 171 | | color. | E 172 | | color. | Gelatina | | Kapselhülle | Kalii Hydroxidum | | | Lacca | | Drucktinte | Per Centum | | | Pro Capsula | | | Propylenglycol | | | Silica Colloidalis Anhydrica | | | Talcum | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
003 | 21 | 726.28 | 806.30 | A | LS | Oui |
|
|